118 related articles for article (PubMed ID: 16825908)
1. Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease.
Müller S; Arni S; Varga L; Balsiger B; Hersberger M; Maly F; Seibold F
Eur J Gastroenterol Hepatol; 2006 Aug; 18(8):889-94. PubMed ID: 16825908
[TBL] [Abstract][Full Text] [Related]
2. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
3. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls.
Chen W; Li D; Wilson I; Chadwick VS
J Gastroenterol Hepatol; 2002 Sep; 17(9):987-93. PubMed ID: 12167120
[TBL] [Abstract][Full Text] [Related]
4. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
5. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
[TBL] [Abstract][Full Text] [Related]
6. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Crohn's disease and CARD15 mutation in a small township in Sicily.
Cottone M; Renda MC; Mattaliano A; Oliva L; Fries W; Criscuoli V; Modesto I; Scimeca D; Maggio A; Casà A; Maisano S; Mocciaro F; Sferrazza A; Orlando A
Eur J Epidemiol; 2006; 21(12):887-92. PubMed ID: 17160430
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.
Schäffler H; Kaschitzki A; Alberts C; Bodammer P; Bannert K; Köller T; Warnke P; Kreikemeyer B; Lamprecht G
Int J Colorectal Dis; 2016 May; 31(5):961-971. PubMed ID: 26951181
[TBL] [Abstract][Full Text] [Related]
9. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.
Heliö T; Halme L; Lappalainen M; Fodstad H; Paavola-Sakki P; Turunen U; Färkkilä M; Krusius T; Kontula K
Gut; 2003 Apr; 52(4):558-62. PubMed ID: 12631669
[TBL] [Abstract][Full Text] [Related]
10. NOD2/CARD15 Mutations among Bedouin Arabs with Inflammatory Bowel Disease: Frequency and Phenotype Correlation.
Abu Freha N; Badarna W; Abu Tailakh M; Abu Kaf H; Fich A; Schwartz D; Segal A; Elkrinawi J; Karban A
Isr Med Assoc J; 2018 Nov; 20(11):695-699. PubMed ID: 30430799
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
[TBL] [Abstract][Full Text] [Related]
12. Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease.
Bernstein CN; Wang MH; Sargent M; Brant SR; Collins MT
J Clin Microbiol; 2007 Mar; 45(3):968-71. PubMed ID: 17251406
[TBL] [Abstract][Full Text] [Related]
13. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.
Tolentino YF; Elia PP; Fogaça HS; Carneiro AJ; Zaltman C; Moura-Neto R; Luiz RR; Carvalho Mda G; de Souza HS
Dig Dis Sci; 2016 Sep; 61(9):2636-47. PubMed ID: 27107867
[TBL] [Abstract][Full Text] [Related]
14. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
[TBL] [Abstract][Full Text] [Related]
15. NOD2 gene mutations associate weakly with ulcerative colitis but not with Crohn's disease in Indian patients with inflammatory bowel disease.
Pugazhendhi S; Santhanam S; Venkataraman J; Creveaux I; Ramakrishna BS
Gene; 2013 Jan; 512(2):309-13. PubMed ID: 23085276
[TBL] [Abstract][Full Text] [Related]
16. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
17. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
[TBL] [Abstract][Full Text] [Related]
18. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis.
Brant SR; Wang MH; Rawsthorne P; Sargent M; Datta LW; Nouvet F; Shugart YY; Bernstein CN
Am J Gastroenterol; 2007 Feb; 102(2):313-23. PubMed ID: 17100976
[TBL] [Abstract][Full Text] [Related]
19. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
20. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
